stella
beta
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer — Stella
Recruiting
Back to Endometrial Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut
View full record on ClinicalTrials.gov